MX2020000816A - Tratamiento de lesiones no inflamatorias. - Google Patents
Tratamiento de lesiones no inflamatorias.Info
- Publication number
- MX2020000816A MX2020000816A MX2020000816A MX2020000816A MX2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A MX 2020000816 A MX2020000816 A MX 2020000816A
- Authority
- MX
- Mexico
- Prior art keywords
- methyl
- inflammatory lesions
- mono
- naphthacene
- tetrahydroxy
- Prior art date
Links
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 title abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- PQJQFLNBMSCUSH-SBAJWEJLSA-N chembl2364632 Chemical compound O=C1C2=C(O)[C@@](C(C(C(N)=O)=C(O)[C@H]3N(C)C)=O)(O)[C@H]3C[C@@H]2CC2=C1C(O)=CC=C2CN(C)OC PQJQFLNBMSCUSH-SBAJWEJLSA-N 0.000 abstract 1
- -1 methoxy(methyl)amino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762535572P | 2017-07-21 | 2017-07-21 | |
| PCT/IB2018/000938 WO2019016609A1 (en) | 2017-07-21 | 2018-07-20 | TREATMENT OF NON-INFLAMMATORY LESIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020000816A true MX2020000816A (es) | 2020-08-17 |
Family
ID=63713912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020000816A MX2020000816A (es) | 2017-07-21 | 2018-07-20 | Tratamiento de lesiones no inflamatorias. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200222432A1 (https=) |
| EP (1) | EP3654988B1 (https=) |
| JP (1) | JP2020527607A (https=) |
| KR (1) | KR102662461B1 (https=) |
| CN (1) | CN111343991A (https=) |
| AU (1) | AU2018303807B2 (https=) |
| BR (1) | BR112020000968A2 (https=) |
| CA (1) | CA3070663A1 (https=) |
| ES (1) | ES2962380T3 (https=) |
| IL (1) | IL272124A (https=) |
| MA (1) | MA49641A (https=) |
| MX (1) | MX2020000816A (https=) |
| WO (1) | WO2019016609A1 (https=) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990331A (en) | 1956-11-23 | 1961-06-27 | Pfizer & Co C | Stable solutions of salts of tetracyclines for parenteral administration |
| US2980584A (en) | 1957-10-29 | 1961-04-18 | Pfizer & Co C | Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3062717A (en) | 1958-12-11 | 1962-11-06 | Pfizer & Co C | Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3165531A (en) | 1962-03-08 | 1965-01-12 | Pfizer & Co C | 13-substituted-6-deoxytetracyclines and process utilizing the same |
| US3454697A (en) | 1965-06-08 | 1969-07-08 | American Cyanamid Co | Tetracycline antibiotic compositions for oral use |
| NL6607516A (https=) | 1966-05-31 | 1967-12-01 | ||
| DE1767891C3 (de) | 1968-06-28 | 1980-10-30 | Pfizer | Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat |
| US3957980A (en) | 1972-10-26 | 1976-05-18 | Pfizer Inc. | Doxycycline parenteral compositions |
| DE2442829A1 (de) | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
| US4018889A (en) | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
| US4126680A (en) | 1977-04-27 | 1978-11-21 | Pfizer Inc. | Tetracycline antibiotic compositions |
| AU2002303250B2 (en) * | 2001-04-05 | 2006-05-25 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
| US7704959B2 (en) * | 2006-10-03 | 2010-04-27 | Dow Pharmaceutical Sciences | Azithromycin for the treatment of nodular acne |
| PL2109602T3 (pl) | 2006-12-21 | 2014-09-30 | Paratek Pharm Innc | Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych |
| PT2120963T (pt) | 2006-12-21 | 2018-12-17 | Paratek Pharm Innc | Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele |
| EP2280733A1 (en) * | 2008-05-21 | 2011-02-09 | Galderma Research & Development | Maintenance therapy regimen for treating acne |
| CA2723029C (en) * | 2008-06-05 | 2016-07-19 | Dow Pharmaceutical Sciences, Inc. | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| CA2769640A1 (en) * | 2009-07-30 | 2011-02-03 | Allergan, Inc. | Combination of dapsone with adapalene |
| US20140121188A1 (en) * | 2009-10-02 | 2014-05-01 | Foamix Ltd. | Compositions for the improved treatment of acne and related disorders |
| US9255068B2 (en) | 2011-05-12 | 2016-02-09 | Warner Chilcott Company, Llc | Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same |
| IL225239A0 (en) * | 2012-03-15 | 2013-06-27 | Meir Eini | Compounds for the treatment of acne and related diseases |
| GB201615693D0 (en) * | 2016-09-15 | 2016-11-02 | Combinatorx Infection Ltd | Combinations |
-
2018
- 2018-07-20 CN CN201880048978.1A patent/CN111343991A/zh active Pending
- 2018-07-20 WO PCT/IB2018/000938 patent/WO2019016609A1/en not_active Ceased
- 2018-07-20 CA CA3070663A patent/CA3070663A1/en active Pending
- 2018-07-20 MA MA049641A patent/MA49641A/fr unknown
- 2018-07-20 US US16/632,121 patent/US20200222432A1/en not_active Abandoned
- 2018-07-20 EP EP18779747.7A patent/EP3654988B1/en active Active
- 2018-07-20 ES ES18779747T patent/ES2962380T3/es active Active
- 2018-07-20 AU AU2018303807A patent/AU2018303807B2/en active Active
- 2018-07-20 KR KR1020207003934A patent/KR102662461B1/ko active Active
- 2018-07-20 JP JP2020524697A patent/JP2020527607A/ja active Pending
- 2018-07-20 MX MX2020000816A patent/MX2020000816A/es unknown
- 2018-07-20 BR BR112020000968-7A patent/BR112020000968A2/pt not_active Application Discontinuation
-
2020
- 2020-01-19 IL IL272124A patent/IL272124A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3654988B1 (en) | 2023-09-06 |
| US20200222432A1 (en) | 2020-07-16 |
| JP2020527607A (ja) | 2020-09-10 |
| KR20200031126A (ko) | 2020-03-23 |
| CN111343991A (zh) | 2020-06-26 |
| EP3654988A1 (en) | 2020-05-27 |
| AU2018303807B2 (en) | 2023-08-24 |
| CA3070663A1 (en) | 2019-01-24 |
| MA49641A (fr) | 2021-06-02 |
| AU2018303807A1 (en) | 2020-02-13 |
| IL272124A (en) | 2020-03-31 |
| WO2019016609A1 (en) | 2019-01-24 |
| ES2962380T3 (es) | 2024-03-18 |
| KR102662461B1 (ko) | 2024-04-30 |
| BR112020000968A2 (pt) | 2020-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4424328A3 (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| CA2588296A1 (en) | Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease | |
| US10085959B2 (en) | Compositions and methods for treating intestinal hyperpermeability | |
| RU2014111069A (ru) | Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение | |
| MA35090B1 (fr) | Polythérapie pour les malignités hématologiques | |
| IL273169B1 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
| AU2014340303A1 (en) | Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability | |
| FI3493812T3 (fi) | Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten | |
| RU2013108258A (ru) | Применение разагилина для лечения обонятельной дисфункции | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| JP2024516795A5 (https=) | ||
| RU2018110580A (ru) | Проникающее в мозг производное оксима хромона для терапии леводопа-индуцированной дискинезии | |
| MX2023005078A (es) | Nuevas formas cristalinas de un compuesto inhibidor de kras g12c. | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| FI3864053T3 (fi) | Rms:n hoito vaihtohoidolla | |
| DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
| MX2020000816A (es) | Tratamiento de lesiones no inflamatorias. | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
| RU2020108631A (ru) | Новая вспомогательная терапия для применения в способе лечения рака простаты | |
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| RU2013149635A (ru) | Соединения солифенацина и слюнные стимулянты для лечения гиперактивности мочевого пузыря | |
| UY38340A (es) | Combinación farmacéutica sinérgica que comprende tramadol clorhidrato y pregabalina, y su uso para el tratamiento del dolor neuropático |